Background: Statins have recently been shown to exert neuronal protection in ischemic
Methods: Transient focal ischemia was created in halothane-anesthetized adult male Sprague-Dawley rats (250-300 g) by middle cerebral artery occlusion (MCAO). Atorvastatin The cellular mechanisms involved in ischemic brain injury are multifactorial and remain incompletely understood. Reactive oxygen species (ROS) formed during ischemia and reperfusion contribute to neuronal injury, and suppression of ROS alleviates oxidative stress-induced neuronal damage (1) . Superoxide is the first ROS generated in the oxygen free radical chain during the early phase of reperfusion and contributes to neuronal injury (9) .
NADPH oxidase is a principal enzyme for the production of superoxide (4) . It is expressed in both neural and non-neural cell types of the central nervous system (CNS), including cerebral cortical neurons, hippocampal pyramidal neurons, cerebellar Purkinjie cells as well as microglial cells, monocytes and neutrophils (3, 17) . NADPH oxidase is a complex enzyme that consists of the membrane subunit cytochrome b 558 (p22 , which is the catalytic subunit of the enzyme, has been shown to be augmented in ischemic stroke (7) . Conversely, gp91 phox mutant mice (X-CGD) exhibits reduced cerebral infarction (21) . These findings indicate that NADPH oxidase plays a key role in ROS-induced neuronal damage in ischemic stroke.
HMG-CoA reductase inhibitors (statins), the mainstay cholesterol-lowering agents, have recently been shown to protect against ischemic stroke independent of their lipid lowering effect (13) . An important mechanism by which statins create their protective effects on ischemic stroke is by the upregulation of endothelial nitric oxide synthase (eNOS) (13) .
Additionally, some studies have shown that statins also possess antioxidant effect and can down-regulate NADPH oxidase in cultured rat aortic smooth muscle cells (14) . Therefore, the present study tested the hypothesis that statins protects against cerebral infarction by 
Materials and Methods

Animal and drug preparations
Adult male Sprague-Dawley rats (250-300g) were housed in groups (three rats per 
Physiological Measurements
Blood pressure and heart rate were continuously measured with a transducer recorder (model Quad Bridge ML118, AD Instruments) from 15 min before the MCAO procedure to 15 min afterwards as we previously described (8) . Regional cerebral blood flow (CBF) was measured with a laser Doppler perfusion monitor (PERIMED) (8) . Briefly, a small incision was made at the midpoint between the left orbit and the external auditory canal under anesthesia. The temporalis muscle was retracted, and the underlying fascia was cleared. A small area of skull approximately 1 mm posterior and 5 mm lateral to the bregma was thinned 
Focal cerebral ischemia
Rats were anesthetized with 1.5% halothane and maintained on 1.0% halothane in 70% N 2 O and 30% O 2 with face mask. Body temperature was monitored by a rectal probe and maintained at 37-37.5°C by an automatic homeothermic blanket control unit (Harvard Apparatus). The physical parameters of all rats included in the study were within normal limits. MCAO model was established by proximal occlusion of the left MCA with the use of a nylon monofilament as we previously described (8) . Briefly, after a 2-hour occlusion, reperfusion was accomplished by careful withdrawal of the monofilament. The common carotid artery was ligated distal to the incision. The time of reperfusion (0 to 24 hours) depended on the experimental design. After reperfusion, brains were harvested for the various measurements as described below. Infarct volume was evaluated by 2,3,5-triphenyltetrazolium chloride (TTC) staining as described (7, 8) .
Ischemic core and penumbra dissections
The ischemic core and penumbra were dissected according to the well established protocols in rodent models of unilateral proximal MCAO (1). Briefly, a longitudinal cut from dorsal to ventral approximately 1.5 mm from the midline was made through each hemispheres to exclude medial brain structures, which supplied primarily by the anterior cerebral artery. A transverse diagonal cut at approximately the "2 o'clock" position was then made to separate the core from the penumbra (1). NADPH oxidase enzymatic activity and superoxide levels were quantified by the lucigenin-enhanced chemiluminescence as we described previously (11, 12) . For NADPH oxidase assay, brain tissues from the ischemic core and penumbra were homogenized and centrifuged, and the supernatants were assayed for protein concentration (Bio-Rad). NADPH oxidase activity was measured in the supernatants in the presence of its substrate NADPH (10 -4 mol/L, Sigma) and lucigenin (5x10 Photomultiplier background signal was determined in brain-free preparations and automatically subtracted. The adjusted readings were then converted to nmol/min/mg tissue via a standard curve generated by cytochrome C (Sigma) reduction from superoxide derived from hypoxanthine (Sigma) and xanthine oxidase (Sigma).
Measurements of brain NADPH oxidase activity and superoxide levels
Extraction of membrane-bound proteins by subcellular fractionation
Differential centrifugation was used for isolation of membrane proteins as described (15) . Briefly, brain tissues were homogenized in ice-cold HEPES buffer (20 mM HEPES, 150 mM NaCl and 1 mM EDTA, pH 7.4), in which the protease inhibitor cocktail (Sigma) was added just before homogenization. The homogenates were centrifuged at 2,800g at 4 The sample proteins, which were extracted as described above, were subjected to electrophoresis on SDS-PAGE. The separated proteins were transferred by electrophoresis to holyvinylidine difluoride (PVDF) membranes as we described (11) . The membranes were incubated with anti-gp91 The unpaired Student's t-test was used to compare two-group data (i.e. cerebral infarct volume). Values of pዊ0.05 were considered to be statistically significant.
Results
Physiological parameters
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As shown in the Table, blood pressure and heart rate, as monitored from 15 min before MCAO procedure to 15 min after the procedure, were found to be not significantly different for the entire procedure. Regional CBF was reduced to about 15% of the baseline levels (i.e. 100%) as measured prior to MCAO. There was no significant difference in CBF levels between the atorvastatin and the control groups before MCAO.
Atorvastatin reduces infarct volume 24 hours after reperfusion in MCAO rats
Reproducible infarcts in the cerebral cortex and striatum were observed 24 hours after MCAO in control rats (Fig 1A) , which was significantly reduced with atorvastatin pretreatment (44.6±2.7 vs. 21.4±5.1%, p<0.01, n=5-6, Fig 1B) .
Time-dependent changes of NADPH oxidase activity in MCAO rats
As shown in Fig 2, NADPH oxidase activity decreased during the 2-hour ischemic period but increased quickly upon reperfusion in both the core and penumbral regions, reaching its peak levels within 2 hours after reperfusion. It was significantly higher in the penumbra compared to the normal brain tissues of MCAO rats (62.55±7.61 vs. 32.91±1.54 mmol/min/mg protein, p<0.01, n=4-6), but significantly lower in the ischemic core.
Atorvastatin impedes peak NADPH oxidase activity and superoxide levels during reperfusion
Atorvastatin treatment significantly reduced penumbral NADPH oxidase activity of MCAO rats (41.64±2.51 vs. 62.55±7.61 mmol/min/mg protein, p<0.05, n=4-6, Fig 3A) 2 hours after reperfusion, resulting in decreased superoxide levels (0.3±0.07 vs. 0.6±0.04 nmol/min/mg tissue, p<0.001, n=3-4, Fig 3B) . 
Discussion
The major new findings of the present study are that: 1) after a transient decrease in response to ischemia, NADPH oxidase activity in both the penumbral and core regions rapid and marked increases upon reperfusion and peaks within 2 hours thereafter; 2) treatment with atorvastatin 3 times before ischemia blunts the peak enzymatic activity in penumbra by impeding the overexpression of its membrane subunit gp91 phox and membrane translocation of its cytosolic subunit p47 phox , resulting in reduced superoxide levels 2 hours after reperfusion but not cerebral blood flow (CBF), and 3) inhibition of NADPH oxidase accounts, at least in part, for the observed protection of atorvastatin against cerebral infarction in ischemic stroke.
Reactive oxygen species (ROS) are well-known to play a pivotal role in cerebral ischemic-reperfusion cell injury (22) . Superoxide is the first ROS generated in the oxygen free radical chain during the early phase of reperfusion after cerebral ischemia (5) . The interaction of superoxide with nitric oxide (NO) results in the production of peroxynitrite, one of the most harmful ROS species that causes neuronal tissue damage via lipid peroxidation,
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Copyright Information protein oxidation, nitration and DNA breakage (8, 20) . Recent studies indicate that NADPH oxidase is a predominant source of superoxide generation in the vasculature (4) as well as central nervous system (17) . However, the profile of NADPH oxidase activity during cerebral ischemia and reperfusion was unknown. In the present study, we found that NADPH oxidase activity changes in a time-dependent manner during ischemic reperfusion period and is significantly higher in the penumbral compared to the core regions. Throughout the entire course of ischemia, NADPH oxidase activity remains at low levels compared to the normal brain tissues. The low activity of NADPH oxidase may be attributable to the complete blockade of blood flow to the ischemic core area where most cells die quickly due to energy exhaustion. In contrast, penumbral NADPH oxidase activity remains relatively stable during the ischemic phase and sharply increases upon reperfusion before subsides somewhat 2 hours after the reperfusion period. Although the time course of superoxide formation during the entire ischemic reperfusion period was not determined in the present study, we found that penumbral superoxide levels are markedly and significantly higher compared to the core 2 hours after reperfusion. The latter findings are also consistent with the previously published reports (5, 9) . The increased penumbral NADPH oxidase activity and the resultant superoxide generation may thus play an important role in neuronal damage and contribute to the enlargement of the infarct size in the late phase of reperfusion. (6) . In addition, statins exhibit superoxide scavenging properties in the vasculature (16) , which may in part, due to their action on NADPH oxidase (19) . In the present study, we tested the hypothesis that atorvastatin, one of the most widely prescribed statins, protects against cerebral infarction via suppressing NADPH oxidase activity in focal cerebral ischemia. Our findings demonstrate that atorvastatin treatment (10 mg/kg) for 3 times before reperfusion by subcutaneous injection was effective in reducing cerebral infarct volume. This dose regimen has been shown to result in significant neuronal protection (6) . We chose the time point of 2 hours after reperfusion to assess its effect on NADPH oxidase-derived superoxide levels because we found that NADPH oxidase activity has reached its peak levels by then. Our data show that atorvastatin significantly inhibited the increased NADPH oxidase activity and subsequent production of superoxide. Since superoxide is known to interact with NO to form peroxynitrite (7, 8) , which also appears at the early phase of reperfusion (18) , the cellular injury and death caused by the latter might be alleviated in the penumbral region as a result. Consistent with this notion, atorvastatin-treated MCAO rats showed significantly smaller infarct volume 24 hours after reperfusion, perhaps reflecting the dynamic processes in the penumbra during the time course of the reperfusion period.
NADPH oxidase is a complex enzyme that consists of a number of subunits, including the membrane-bound catalytic subunit gp91 phox and the cytoplasmic subunits p47 phox and small G-Protein Rac-1 that translocate to the membrane upon enzyme activation (2).
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Accordingly, the expression of gp91 phox has been shown to be augmented in ischemic stroke (7) , and gp91 phox mutant mice exhibit reduced cerebral infarct volume (20) . In the present study, we determined the protein expression profile of the catalytic subunit gp91 Despite of the aforementioned experimental observations, it is of note that a few issues still remain that could not be addressed by this single study. We observed a relative small but significant increase of gp91phox protein level 4 hours after MCAO, along with an increase of the translocated p47phox (membrane-bound). As the latter may not equal to an increase in new protein expression, these findings suggest that the translocation of the cytosolic subunit of NADPH oxidase (e.g. p47phox) and its subsequent interaction with membrane-bound gp91phox at the protein level, rather than the de novo new enzyme protein synthesis per se, may account for the observed increase of NADPH oxidase enzyme activity.
In addition, the unchanged Rac-1 level at a single time point may not reflect the whole picture of the Rac-1 expression dynamics over time in this model. Hence, future studies will be needed to establish a time-course of protein expression for various NADPH oxidase In conclusion, the present study suggests that NADPH oxidase activity increases quickly and peaks within 2 hours after reperfusion in the penumbral region in MCAO rats, which may represent an important mechanism for the enlargement of the ischemic core. The study demonstrates further that the protective effects of atorvastatin are at least partially mediated by its inhibitive action on NADPH oxidase activity during the early phase of reperfusion in the penumbra, which has been suggested to be a main therapeutic target in acute ischemia stroke. 
